首页> 美国卫生研究院文献>Therapeutic Advances in Psychopharmacology >TARC: Turkish aripiprazole consensus report- Aripiprazole use andswitching from other antipsychotics to aripiprazole- consensus recommendationsby a Turkish multidisciplinary panel
【2h】

TARC: Turkish aripiprazole consensus report- Aripiprazole use andswitching from other antipsychotics to aripiprazole- consensus recommendationsby a Turkish multidisciplinary panel

机译:TARC:土耳其阿立哌唑共识报告-阿立哌唑的使用和从其他抗精神病药转向阿立哌唑-共识推荐土耳其多学科小组成员

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this review, we have attempted to share our 10 years’ clinical experience with aripiprazole use and switching from other antipsychotics to aripiprazole. There are various reasons for switching, including a partial or complete lack of efficacy, adverse side effects, and partial or noncompliance with medication. Aripiprazole has some unique receptor-binding qualities that provides some advantages over other antipsychotics in certain clinical situations. We have covered potential clinical scenarios for aripiprazole use as a single agent and switching from other agents in inpatient and outpatient settings. Patients switched from other antipsychotics to aripiprazole have been shown to benefit from significant improvements in clinical response and tolerability. This review examines the strategies for switching patients from antipsychotic drugs to aripiprazole.
机译:在这篇评论中,我们试图分享我们十年使用阿立哌唑的临床经验,并从其他抗精神病药转向阿立哌唑。换药的原因多种多样,包括部分或完全缺乏疗效,不良副作用以及部分或完全不服药。阿立哌唑具有某些独特的受体结合特性,在某些临床情况下,与其他抗精神病药相比具有某些优势。我们已经涵盖了阿立哌唑作为单一药物使用以及在住院和门诊环境中从其他药物转换的潜在临床方案。从其他抗精神病药物转为使用阿立哌唑的患者已显示出可从临床反应和耐受性的显着改善中受益。这篇综述探讨了将患者从抗精神病药转向阿立哌唑的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号